Skip to main content
. 2014 Dec 29;32(3):159–166. doi: 10.5534/wjmh.2014.32.3.159

Fig. 1.

Fig. 1

Prostate-specific antigen (PSA) progression-free survival in prostate cancer patients on primary androgen-deprivation therapy.